Mar 31, 2023

Y-mAbs Q1 2023 Earnings Report

Y-mAbs Therapeutics, Inc. announced its financial results for the quarter ended March 31, 2023.

Key Takeaways

Y-mAbs Therapeutics, Inc. announced its financial results for the quarter ended March 31, 2023.

Total Revenue
$20.3M
Previous year: $10.5M
+93.1%
EPS
-$0.15
Previous year: -$0.64
-76.6%
Gross Profit
$18.2M
Previous year: $8.66M
+109.9%
Cash and Equivalents
$92.6M
Previous year: $157M
-40.9%
Total Assets
$137M
Previous year: $191M
-28.1%

Y-mAbs

Y-mAbs